Mason Street Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Mason Street Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-53,287	Closed	-$2.87M	–	1524
2017 Q4	$2.87M	Sell	53,287 -397	-0.7%	-$21.7K	0.06%	353
2017 Q3	$3.06M	Buy	53,684 +848	+2%	+$49.7K	0.07%	306
2017 Q2	$3.18M	Buy	52,836 +1,838	+4%	+$105K	0.08%	285
2017 Q1	$2.78M	Buy	+50,998	New	+$2.51M	0.07%	328

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Mason Street Advisors's BIVV Position: Q1 2018 in Review

Mason Street Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 53,287 shares — an estimated $2.87M sold.

Mason Street Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3.18M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Mason Street Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Mason Street Advisors sold 53,287 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.87M.
Mason Street Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Mason Street Advisors's Bioverativ Inc. Common Stock position peaked at $3.18M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Mason Street Advisors's 13F filing for Q1 2018, filed 14 May 2018.